Partnering with Altasciences for your IND/CTA needs will ensure that your application to regulatory agencies moves forward as smoothly and efficiently as possible. To reach your milestones on time, we recommend setting up a meeting to consult with us at least one year before your targeted IND/CTA submission date to allow for program design and ordering of research animals. 

Contact our experts today. 

Altasciences can help you compile the key information necessary to approve your application request, including: 

• Animal pharmacology and toxicology studies to assess safety; 
• Manufacturing processes to ensure consistent batches of the study drug; 
• Clinical protocols and investigator information to assess tolerance and risk. 

For a more detailed overview of the regulatory planning process, consult our Preclinical Assessment Planning Guide. 

You may also be interested in the following: 

• Webinar: Navigating the Challenges of Early Drug Development 
• Fact Sheets: 
  • IND Services for Small Molecules 
  • IND Services for Biologics 

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services.